Publications by authors named "Peter Roberson"

Claim this Profile
P
Prediction of Tumor Control in Y Radioembolization by Logit Models with PET/CT-Based Dose Metrics.
Yuni K Dewaraja, Theresa Devasia, Ravi K Kaza, Justin K Mikell, Dawn Owen, Peter L Roberson

J Nucl Med· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Y PET gradient-based tumor segmentation on voxel-level dosimetry in liver radioembolization.
Justin K Mikell, Ravi K Kaza, Peter L Roberson, Kelly C Younge, Ravi N Srinivasa

EJNMMI Phys· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Beyond Dose: Using Pretherapy Biomarkers to Improve Dose Prediction of Outcomes for Radioimmunotherapy of Non-Hodgkin Lymphoma.
Peter L Roberson, Lauren B Smith, Meredith A Morgan, Matthew J Schipper, Scott J Wilderman

Cancer Biother Radiopharm· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of a brachytherapy audit checklist tool.
Joann Prisciandaro, Scott Hadley, Shruti Jolly, Choonik Lee, Peter Roberson

Brachytherapy· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Using a 2D detector array for meaningful and efficient linear accelerator beam property validations.
Timothy A Ritter, Ian Gallagher, Peter L Roberson

J Appl Clin Med Phys· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumor-Absorbed Dose Predicts Progression-Free Survival Following (131)I-Tositumomab Radioimmunotherapy.
Yuni K Dewaraja, Matthew J Schipper, Jincheng Shen, Lauren B Smith, Jure Murgic, Peter L Roberson

J Nucl Med· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Audit tool for external beam radiation therapy departments.
Timothy Ritter, James M Balter, Choonik Lee, Don Roberts, Peter L Roberson

Pract Radiat Oncol· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biological-effect modeling of radioimmunotherapy for non-hodgkins lymphoma: determination of model parameters.
Peter L Roberson, Scott J Wilderman, Anca M Avram, Mark S Kaminski, Matthew J Schipper

Cancer Biother Radiopharm· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MIRD pamphlet No. 23: quantitative SPECT for patient-specific 3-dimensional dosimetry in internal radionuclide therapy.
Yuni K Dewaraja, Eric C Frey, George Sgouros, A Bertrand Brill, Peter Roberson

J Nucl Med· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bio-effect model applied to 131I radioimmunotherapy of refractory non-Hodgkin's lymphoma.
Peter L Roberson, Hanan Amro, Scott J Wilderman, Anca M Avram, Mark S Kaminski

Eur J Nucl Med Mol Imaging· May 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analysis of variation in calibration curves for Kodak XV radiographic film using model-based parameters.
Shu-Hui Hsu, Ravi Kulasekere, Peter L Roberson

J Appl Clin Med Phys· August 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
1
131I-tositumomab radioimmunotherapy: initial tumor dose-response results using 3-dimensional dosimetry including radiobiologic modeling.
Yuni K Dewaraja, Matthew J Schipper, Peter L Roberson, Scott J Wilderman, Hanan Amro

J Nucl Med· July 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dose discrepancies in the buildup region and their impact on dose calculations for IMRT fields.
Shu-Hui Hsu, Jean M Moran, Yu Chen, Ravi Kulasekere, Peter L Roberson

Med Phys· May 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Methodology to incorporate biologically effective dose and equivalent uniform dose in patient-specific 3-dimensional dosimetry for non-Hodgkin lymphoma patients targeted with 131I-tositumomab therapy.
Hanan Amro, Scott J Wilderman, Yuni K Dewaraja, Peter L Roberson

J Nucl Med· April 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Radiographic film dosimetry for IMRT fields in the nearsurface buildup region.
Peter L Roberson, Jean M Moran, Ravi Kulasekere

J Appl Clin Med Phys· October 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of skin dose for breast chest wall radiotherapy as a function of bolus material.
Shu-Hui Hsu, Peter L Roberson, Yu Chen, Robin B Marsh, Lori J Pierce

Phys Med Biol· May 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Accuracy of rapid radiographic film calibration for intensity-modulated radiation therapy verification.
Ravi Kulasekere, Jean M Moran, Benedick A Fraass, Peter L Roberson

J Appl Clin Med Phys· May 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Surface buildup dose dependence on photon field delivery technique for IMRT.
Shigeru Yokoyama, Peter L Roberson, Dale W Litzenberg, Jean M Moran, Benedick A Fraass

J Appl Clin Med Phys· March 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of day 0 and day 14 dosimetry for permanent prostate implants using stranded seeds.
Patrick McLaughlin, Vrinda Narayana, Charlie Pan, Sally Berri, Sara Troyer, Peter Roberson

Int J Radiat Oncol Biol Phys· January 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeted radiation for melanoma: alpha therapy prepares for a beta test.
Joseph N Contessa, Peter L Roberson

Cancer Biol Ther· January 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Functional anatomy of the prostate: implications for treatment planning.
Patrick W McLaughlin, Sara Troyer, Sally Berri, Vrinda Narayana, Amichay Meirowitz, Peter L Roberson

Int J Radiat Oncol Biol Phys· October 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intraperitoneal radioimmunotherapy with a humanized anti-TAG-72 (CC49) antibody with a deleted CH2 region.
Buck E Rogers, Peter L Roberson, Sui Shen, M B Khazaeli, Mark Carpenter

Cancer Biother Radiopharm· October 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use and uncertainties of mutual information for computed tomography/ magnetic resonance (CT/MR) registration post permanent implant of the prostate.
Peter L Roberson, P William McLaughlin, Vrinda Narayana, Sara Troyer, George V Hixson

Med Phys· February 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vessel-sparing prostate radiotherapy: dose limitation to critical erectile vascular structures (internal pudendal artery and corpus cavernosum) defined by MRI.
Patrick W McLaughlin, Vrinda Narayana, Amichay Meirovitz, Sara Troyer, Peter L Roberson

Int J Radiat Oncol Biol Phys· January 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized trial of high- and low-source strength (125)I prostate seed implants.
Vrinda Narayana, Sara Troyer, Vicki Evans, Raymond J Winfield, Peter L Roberson

Int J Radiat Oncol Biol Phys· January 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis